BMC Developmental Biology · 2010 · 193 citations · 29 references
Life SciencesBioengineeringCell BiologyRegenerative MedicineStem Cell BiologyTissue EngineeringCell CultureCell Culture TechnologyEmbryonic Stem CellsMammalian Cell CulturePluripotent Stem CellsStem Cell BioengineeringCell Culture ConditionsDifferentiationEmbryonic Stem Cell BiologyFeeder-free Cell CultureFeeder-free Embryonic Stem Cell CultureHuman Embryonic Stem CellsInduced Pluripotent Stem CellsPluripotent Stem Cell Safety
BACKGROUND: To maintain pluripotency of human embryonic stem (huES) cells in feeder-free culture it has been necessary to provide a Matrigel substratum, which is a complex of poorly defined extracellular matrices and growth factors derived from mouse Engelbreth-Holm-Swarm sarcoma cells. Culture of stem cells under ill-defined conditions can inhibit the effectiveness of maintaining cells in a pluripotent state and reduce reproducibility of differentiation protocols. Moreover recent batches of Matrigel have been found to be contaminated with the single stranded RNA virus, Lactate Dehydrogenase Elevating Virus (LDEV), raising concerns regarding the safety of using stem cells that have been cultured on Matrigel in a therapeutic setting. To circumvent such concerns, we attempted to identify a recombinant matrix that could be used as an alternative to Matrigel for the culture of human pluripotent stem cells. huES and human induced pluripotent stem (hiPS) cells were grown on plates coated with a fusion protein consisting of E-cadherin and the IgG Fc domain using mTeSR1 medium. RESULTS: Cells grown under these conditions maintained similar morphology and growth rate to those grown on Matrigel and retained all pluripotent stem cell features, including an ability to differentiate into multiple cell lineages in teratoma assays. We, therefore, present a culture system that maintains the pluripotency of huES and hiPS cells under completely defined conditions. CONCLUSIONS: We propose that this system should facilitate growth of stem cells using good manufacturing practices (GMP), which will be necessary for the clinical use of pluripotent stem cells and their derivatives.
29
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
Embryonic Stem Cell Lines Derived from Human Blastocysts
James A. Thomson, Joseph Itskovitz‐Eldor, Sander S. Shapiro et al. · Science · 1998 · 15.9K citations
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto et al. · Science · 2007 · 10.3K citations
Feeder-free growth of undifferentiated human embryonic stem cells
Chunhui Xu, Margaret Inokuma, Jerrod Denham et al. · Nature Biotechnology · 2001 · 1.9K citations
Life Sciences, Biology, Cell Biology +14
Basement membrane complexes with biological activity
Hynda K. Kleinman, Mary L. McGarvey, John R. Hassell et al. · Biochemistry · 1986 · 1.5K citations